Drug Patents owned by Adamis Pharms Corp

1. List of Symjepi drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11141540 ADAMIS PHARMS CORP Syringe devices
Oct, 2036

(13 years from now)

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 15 June, 2017

Treatment: A method for administering a therapeutic dose of epinephrine

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

SYMJEPI family patents

6

United States

4

Australia

2

Hong Kong

2

China

2

Israel

2

Japan

2

European Union

1

Brazil

1

Spain

1

Denmark

1

South Africa

1

Canada

1

New Zealand

1

Portugal

1

Korea, Republic of

1

Russia

1

Mexico

2. List of Zimhi drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11027072 ADAMIS PHARMS CORP Emergency devices
May, 2039

(15 years from now)

US11571518 ADAMIS PHARMS CORP NA
Jun, 2041

(18 years from now)

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 15 October, 2021

Treatment: A method for administering a therapeutic dose of an opioid antagonist comprising an emergency syringe device; A method for administering a therapeutic dose of an opioid antagonist comprising an emerge...

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

ZIMHI family patents

6

United States

1

Australia

1

Canada

1

Korea, Republic of

1

China

1

Israel

1

Japan

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in